GlassScriptPhysician profile
Omar A Araim
NPI 1548474570
$2,725.09
in general payments reported to CMS, 2019-2025
24 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $389 · 2021: $341 · 2022: $487 · 2023: $357 · 2024: $270 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $527.92 | 2019-2025 | Lifestent Solo Vascular Stent, Lutonix Drug Coated Balloon, Ultraverse 014 |
| Artivion, INC. | $525.06 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $287.13 | 2019-2022 | |
| Silk Road Medical, INC. | $178.67 | 2020-2022 | |
| Medtronic, INC. | $157.53 | 2023-2024 | Endurant Iis, Venaseal |
| Tactile Systems Technology INC | $138.22 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Pfizer INC. | $135.78 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $118.06 | 2019-2023 | Eliquis |
| W. L. Gore & Associates, INC. | $116.81 | 2021-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cardiovascular Systems INC. | $76.10 | 2020-2022 | |
| Organogenesis INC. | $57.29 | 2023-2024 | Puraply |
| Lemaitre Vascular, INC. | $53.87 | 2023-2024 | Restoreflow |
| Smith+Nephew, INC. | $52.74 | 2020-2024 | Stravix Pl |
| Ethicon US, LLC | $44.08 | 2023 | Vistaseal |
| Becton, Dickinson and Company | $39.59 | 2025 | Rotarexs 6 F X 135 Cm, Progel Applicator Spray Tips |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $37.99 | 2024 | Evoke |
| Medtronic Vascular, INC. | $37.54 | 2019-2020 | |
| Abbott Laboratories | $32.45 | 2020-2025 | Perclose Prostyle |
| Reflow Medical INC | $27.87 | 2025 | |
| Boston Scientific Corporation | $22.28 | 2020 | |
| Bolton Medical INC | $16.66 | 2021 | |
| Getinge USA Sales, LLC | $15.35 | 2019 | |
| Endologix LLC | $14.71 | 2020 | |
| Asahi Intecc USA, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Araim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.